FDA 表示,Abeona 必须满足额外的CMC 要求才...查看全文
Abeona Therapeutics(ABEO)02-15 05:25
$Abeona Therapeutics(ABEO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000935836-24-000200 Act: 34 Size: 47 KB 网页链接查看全文
Abeona Therapeutics(ABEO)03-16 05:05
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-010132 Size: 5 KB 网页链接查看全文
Abeona Therapeutics(ABEO)02-15 05:55
$Abeona Therapeutics(ABEO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-023895 Act: 34 Size: 59 KB 网页链接查看全文
Abeona Therapeutics(ABEO)02-07 21:35
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-005208 Size: 5 KB 网页链接查看全文
Abeona Therapeutics(ABEO)02-13 06:25
$Abeona Therapeutics(ABEO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193805-24-000176 Act: 34 Size: 104 KB 网页链接查看全文
Abeona Therapeutics(ABEO)03-18 20:45
$Abeona Therapeutics(ABEO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001493152-24-010206 Act: 34 Size: 292 KB 网页链接查看全文
Abeona Therapeutics(ABEO)04-23 04:15
$Abeona Therapeutics(ABEO)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-24-015531 Act: 34 Size: 244 KB 网页链接查看全文
Abeona Therapeutics(ABEO)02-15 03:45
$Abeona Therapeutics(ABEO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001172661-24-001247 Act: 34 Size: 91 KB 网页链接查看全文
Abeona Therapeutics(ABEO)03-19 19:25
$Abeona Therapeutics(ABEO)$ DEF 14A Other definitive proxy statements Accession Number: 0001493152-24-010421 Act: 34 Size: 1 MB 网页链接查看全文
chuminhua04-23 11:46
4/22,Abeona Therapeutics $Abeona Therapeutics(ABEO)$ 表示,其针对隐性营养不良性大疱性表皮松解症 (DEB) 患者的自体基因校正细胞疗法 prademagene zamikeracel (pz-cel) 收到了 FDA 的完整回复信 (CRL)。 该公司股价周一盘后交易中暴跌 51%。
FDA 表示,Abeona 必须满足额外的CMC 要求才...查看全文
产业链观察2023-11-27 22:14
#药闻简讯# $Abeona Therapeutics(ABEO)$ FDA接受并授予Pz-cel BLA的优先审评。
PDUFA 05/25/24.
FDA目前不打算举办AdComm查看全文
SeekingBiotech2023-07-29 20:29
ABEO announced that it has completed the submission of the briefing package to the FDA for its pre-Biologics License Application (BLA) meeting in August 2023$Abeona Therapeutics(ABEO)$查看全文
牛唐2023-07-10 20:22
医药板块速评(2022.07.07)
1、多个7月有数据发布的BIotech股价启动,哪些有配置机会?
2、$Abeona Therapeutics(ABEO)、$居里(CRIS)纷纷增发,是否有上车机会?
3、$Wolfspeed(WOLF)$ 、$ETFMG Alternative Harvest ETF(MJ)$ 、$油气服务ETF-Market Vectors(OIH)$ 等异动,后续走势...查看全文
SeekingBiotech2023-06-09 22:39
$Abeona Therapeutics(ABEO)$
基因治疗候选新药。需要补充材料。
营养不良性大疱性表皮松解症(DEB)(包括隐性营养不良性大疱性表皮松解症-RDEB)
Abeona Therapeutics Announces Regulatory Update on Biologics License Application (BLA) for EB-101查看全文
智通财经APP获悉,11月27日,Abeona Therapeutics(ABEO.US)宣布,美国FDA已接受其在研疗法pz-cel(prademagene zamikeracel,EB-101)的生物制品许可申请(BLA),并授予优先审评资格,该疗法是一款自体、COL7A1基因校正表皮片,用于隐性... 网页链接
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-22-027048 Size: 5 KB 网页链接
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-22-027051 Size: 5 KB 网页链接
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-22-027052 Size: 5 KB 网页链接
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-22-027041 Size: 5 KB 网页链接
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-22-027042 Size: 5 KB 网页链接
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-22-027045 Size: 4 KB 网页链接
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-22-026569 Size: 5 KB 网页链接
$Abeona Therapeutics(ABEO)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001493152-22-024500 Act: 33 Size: 315 KB 网页链接
$Abeona Therapeutics(ABEO)$ 8-K Current report, item 5.07 Accession Number: 0001493152-22-023332 Act: 34 Size: 246 KB 网页链接
$Abeona Therapeutics(ABEO)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001493152-22-021969 Act: 34 Size: 5 MB 网页链接